SCHEMBL4853092

SCHEMBL4853092

CCOc1ccc(-c2nc(SC)c(C#N)c(=O)n2-c2ccc(S(=O)(=O)Cl)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.41
TSHR P16473 3/20 0.41
USP2 O75604 2/20 0.41
KDM4E B2RXH2 4/20 0.39
HPGD P15428 4/20 0.38
HSD17B10 Q99714 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MAPT P10636 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
POLB P06746 1/20 0.38
PTPN1 P18031 1/20 0.38
NPSR1 Q6W5P4 2/20 0.38
PTGS2 P35354 2/20 0.38
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
PTGS1 P23219 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
ADORA2B P29275 1/20 0.37
ADORA1 P30542 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4863190 0.88 ALDH1A1 (0.43) ALDH1A1TSHRUSP2KDM4EHPGD
SCHEMBL4860977 0.87 HPGD (0.51) ALDH1A1TSHRUSP2KDM4EHPGD
SCHEMBL4856185 0.87 ALDH1A1 (0.45) ALDH1A1TSHRUSP2KDM4EHPGD
SCHEMBL4861826 0.83 HSD17B10 (0.41) ALDH1A1USP2KDM4EHPGDHSD17B10
SCHEMBL4859624 0.79 PTGS2 (0.46) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL4861850 0.78 PTGS2 (0.47) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL6141883 0.78 PTGS2 (0.47) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL6141923 0.77 PTGS2 (0.51) KDM4EPTGS2PTGS1
SCHEMBL6141813 0.77 PTGS2 (0.51) KDM4EPTGS2PTGS1
SCHEMBL4862257 0.77 ALDH1A1 (0.49) ALDH1A1KDM4EHPGDMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259891-A1 Novel pyrimidon derivatives ORCHID CHEMICAL & PHARMACEUTICALS LIMITED (IN) 2004-12-23 US claimed
US-7365069-B2 Pyrimidone derivatives BEXEL PHARMACEUTICALS INC. (US) 2008-04-29 US disclosed
US-7365069-B2 Pyrimidone derivatives BEXEL PHARMACEUTICALS INC. (US) 2008-04-29 US disclosed
US-20040259891-A1 Novel pyrimidon derivatives ORCHID CHEMICAL & PHARMACEUTICALS LIMITED (IN) 2004-12-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259891-A1 Novel pyrimidon derivatives TYMS, TPMT, TYMP ALDH1A1 272/4885TSHR 2911/4885USP2 4392/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.